The emergence of outbreaks or intentional release of potentially infectious agents is a worldwide concern. CeBGID focuses on the development of molecular therapeutic agents through the design and development of aptamers, interfering RNA and CRISPR / Cas9 technology to develop prevention platforms that allow the inhibition of highly infectious and tropical agents. These activities allow to develop technology that will ensure neutralizing a negative impact to the human and animal popualtion.